Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
New drugs for myelofibrosis
Gabriela Hobbs, Ruben Mesa
Hematology/Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New drugs for myelofibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Primary Myelofibrosis
100%
INCB018424
53%
Pharmaceutical Preparations
32%
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
22%
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
22%
Janus Kinase Inhibitors
15%
Telomerase
12%
Splenomegaly
12%
Expert Testimony
11%
Phosphatidylinositol 3-Kinases
11%
Leukemia
9%
Molecular Biology
9%
Fibrosis
8%
Neoplasms
7%
Mutation
6%
Therapeutics
3%
Social Sciences
drug
54%
expert opinions
30%
Clinical Practice
24%